United States Thapsigargin Market by Application Thapsigargin, a potent inhibitor of sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), has gained significant attention in various applications within the United States market. One of the primary applications is in cancer research and therapy. Thapsigargin’s ability to induce apoptosis selectively in cancer cells by disrupting calcium […]